Developing a Novel Indolocarbazole as Histone Deacetylases Inhibitor against Leukemia Cell Lines
A novel indolocarbazole (named as ZW2-1) possessing HDAC inhibition activity was synthesized and evaluated against human leukemia cell lines HL-60 and NB4. ZW2-1 performed anti-population growth effect which was in a concentration-dependent manner (2–12 μM) by inducing both apoptosis and autophagy i...
Saved in:
| Main Authors: | Wenjing Wang, Maomin Lv, Xiong Zhao, Jingang Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Analytical Methods in Chemistry |
| Online Access: | http://dx.doi.org/10.1155/2015/675053 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of resistance to histone deacetylase inhibitors in acute leukemia
by: Mohammad Amin Akbarzadeh, et al.
Published: (2024-12-01) -
Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia
by: Anali Del Milagro Bernabe Garnique, et al.
Published: (2025-04-01) -
Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases
by: Maria A. Theodoropoulou, et al.
Published: (2024-12-01) -
Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
by: Tianyi Zhang, et al.
Published: (2022-05-01) -
Antiplasmodial activity of pentyloxyamide-based histone deacetylase inhibitors against Plasmodium falciparum parasites
by: Wisam A. Dawood, et al.
Published: (2025-12-01)